Related references
Note: Only part of the references are listed.Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naive infants
Sarah K. Browne et al.
VACCINE (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Abishek Chandrashekar et al.
SCIENCE (2020)
Rapid COVID-19 vaccine development
Barney S. Graham
SCIENCE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
Paul-Henri Lambert et al.
VACCINE (2020)
COVID-19 update: Covid-19-associated coagulopathy
Richard C. Becker
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open -label, phase 1 trial
Till Koch et al.
LANCET INFECTIOUS DISEASES (2020)
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Pedro M. Folegatti et al.
LANCET INFECTIOUS DISEASES (2020)
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
Kelvin Kai-Wang To et al.
LANCET INFECTIOUS DISEASES (2020)
The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement
Peter J. Hotez et al.
MICROBES AND INFECTION (2020)
The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease Insights From Cardiovascular Aging Science
Majd AlGhatrif et al.
JAMA CARDIOLOGY (2020)
Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (BARS-CoV-2) Patients with Outcome and Symptoms
Kimon Argyropoulos et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Dorottya Laczko et al.
IMMUNITY (2020)
Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis
Anne Weiss et al.
EBIOMEDICINE (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
Viral dynamics in mild and severe cases of COVID-19
Yang Liu et al.
LANCET INFECTIOUS DISEASES (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Ann M. Arvin et al.
NATURE (2020)
Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models
Meagan E. Deming et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists
Fiorella Calabrese et al.
VIRCHOWS ARCHIV (2020)
A leading coronavirus vaccine trial is on hold: scientists react
Nicky Phillips et al.
NATURE (2020)
CONCERNS INTENSIFY OVER UPCOMING COVID-VACCINE RESULTS
Smriti Mallapaty et al.
NATURE (2020)
Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach
Moncef Slaoui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Prabhu S. Arunachalam et al.
SCIENCE (2020)
Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
Robert W. Cross et al.
VIROLOGY JOURNAL (2020)
Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States
Roosecelis B. Martines et al.
EMERGING INFECTIOUS DISEASES (2020)
The role of IgG Fc receptors in antibody-dependent enhancement
Stylianos Bournazos et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Age-related rhesus macaque models of COVID-19
Pin Yu et al.
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2020)
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad et al.
LANCET INFECTIOUS DISEASES (2019)
A review of Dengvaxia?: development to deployment
Stephen J. Thomas et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Dengue vaccine: WHO position paper, September 2018-Recommendations
[Anonymous]
VACCINE (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Viral-Induced Enhanced Disease Illness
Maria K. Smatti et al.
FRONTIERS IN MICROBIOLOGY (2018)
Antibody-dependent enhancement of severe dengue disease in humans
Leah C. Katzelnick et al.
SCIENCE (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis
Louise E. Lansbury et al.
VACCINE (2017)
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
Katherine V. Houser et al.
PLOS PATHOGENS (2017)
Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity
Jae-Hoon Ko et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015
Pyoeng Gyun Choe et al.
EMERGING INFECTIOUS DISEASES (2017)
Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Jincun Zhao et al.
IMMUNITY (2016)
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
April M. Killikelly et al.
SCIENTIFIC REPORTS (2016)
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
Anurodh Shankar Agrawal et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Measles and Measles Vaccination A Review
Johan Christiaan Bester
JAMA PEDIATRICS (2016)
Antibody Response and Disease Severity in Healthcare Worker MERS Survivors
Abeer N. Alshukairi et al.
EMERGING INFECTIOUS DISEASES (2016)
A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
Karuppiah Muthumani et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang et al.
NATURE COMMUNICATIONS (2015)
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge
Jiaming Lan et al.
EBIOMEDICINE (2015)
Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
Yoshikazu Honda-Okubo et al.
JOURNAL OF VIROLOGY (2015)
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Sheng-Fan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection
Rudragouda Channappanavar et al.
JOURNAL OF VIROLOGY (2014)
The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance
Lisa A. Lee et al.
VACCINE (2013)
Molecular Determinants of Severe Acute Respiratory Syndrome Coronavirus Pathogenesis and Virulence in Young and Aged Mouse Models of Human Disease
Matthew Frieman et al.
JOURNAL OF VIROLOGY (2012)
Primary Severe Acute Respiratory Syndrome Coronavirus Infection Limits Replication but Not Lung Inflammation upon Homologous Rechallenge
Candice Clay et al.
JOURNAL OF VIROLOGY (2012)
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Michael T. Osterholm et al.
LANCET INFECTIOUS DISEASES (2012)
CURRENT CONCEPTS Dengue
Cameron P. Simmons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLOS ONE (2012)
Algorithm to assess causality after individual adverse events following immunizations
Neal A. Halsey et al.
VACCINE (2012)
Feline infectious peritonitis: Role of the feline coronavirus 3c gene in intestinal tropism and pathogenicity based upon isolates from resident and adopted shelter cats
Niels C. Pedersen et al.
VIRUS RESEARCH (2012)
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent FcγR Pathway
Martial Jaume et al.
JOURNAL OF VIROLOGY (2011)
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
Ana Clara Monsalvo et al.
NATURE MEDICINE (2011)
T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice
Jincun Zhao et al.
JOURNAL OF VIROLOGY (2010)
Association between the 2008-09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring-Summer 2009: Four Observational Studies from Canada
Danuta M. Skowronski et al.
PLOS MEDICINE (2010)
Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates
Saskia L. Smits et al.
PLOS PATHOGENS (2010)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a US Metropolitan Population
Emily G. Severance et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
Fumihiko Yasui et al.
JOURNAL OF IMMUNOLOGY (2008)
T cell responses to whole SARS coronavirus in humans
Chris Ka-fai Li et al.
JOURNAL OF IMMUNOLOGY (2008)
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Julie E. Martin et al.
VACCINE (2008)
The SARS-CoV ferret model in an infection-challenge study
Yong-Kyu Chu et al.
VIROLOGY (2008)
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
Damon Deming et al.
PLOS MEDICINE (2006)
Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63
KH Chan et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2005)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
M Czub et al.
VACCINE (2005)
Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes
NJ Temperton et al.
EMERGING INFECTIOUS DISEASES (2005)
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
H Weingartl et al.
JOURNAL OF VIROLOGY (2004)
Detection of SARS coronavirus in plasma by real-time RT-PCR
PR Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates
MY Wang et al.
HYPERTENSION (2003)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
A role for immune complexes in enhanced respiratory syncytial virus disease
FP Polack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine
GA Prince et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Share Paper
